| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▼ | 1.37▼ | 1.37▼ | 1.39▼ | 1.39▼ |
| MA10 | 1.38▼ | 1.39▼ | 1.39▼ | 1.40▼ | 1.50▼ |
| MA20 | 1.40▼ | 1.40▼ | 1.40▼ | 1.41▼ | 1.55▼ |
| MA50 | 1.43▼ | 1.43▼ | 1.42▼ | 1.51▼ | 1.85▼ |
| MA100 | 1.42▼ | 1.43▼ | 1.46▼ | 1.56▼ | 1.24▲ |
| MA200 | 1.46▼ | 1.54▼ | 1.54▼ | 1.78▼ | 1.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.007▼ | -0.007▼ | -0.001▼ | -0.017▼ |
| RSI | 32.492▼ | 34.586▼ | 35.342▼ | 38.480▼ | 42.663▼ |
| STOCH | 28.472 | 54.588 | 47.854 | 48.099 | 16.384▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -80.008▼ | -91.667▼ |
| CCI | -187.060▼ | -190.071▼ | -192.555▼ | -119.169▼ | -106.234▼ |
|
Thursday, July 09, 2026 05:12 AM
First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients ...
|
|
Tuesday, July 07, 2026 05:59 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Thursday, April 02, 2026 05:01 PM
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 1.44 | 1.44 | 1.31 | 1.33 | 113,172 |
| 09/07/26 | 1.39 | 1.44 | 1.34 | 1.40 | 69,684 |
| 08/07/26 | 1.40 | 1.44 | 1.35 | 1.38 | 31,383 |
| 07/07/26 | 1.45 | 1.455 | 1.28 | 1.39 | 66,246 |
| 06/07/26 | 1.44 | 1.4599 | 1.39 | 1.44 | 49,118 |
| 02/07/26 | 1.46 | 1.46 | 1.4044 | 1.42 | 18,899 |
| 01/07/26 | 1.42 | 1.4513 | 1.40 | 1.42 | 16,865 |
| 30/06/26 | 1.43 | 1.43 | 1.41 | 1.41 | 11,770 |
| 29/06/26 | 1.38 | 1.45 | 1.3799 | 1.43 | 51,009 |
| 26/06/26 | 1.36 | 1.38 | 1.32 | 1.36 | 43,621 |
|
|
||||
|
|
||||
|
|